This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Cramer's Action Alerts PLUS - See his portfolio and get alerts BEFORE every trade. Learn more NOW!

The Cloudburst Group Appoints Vladimir Knezevic, MD, As Director, Center For Public Health

LANDOVER, Md., Nov. 26, 2012 /PRNewswire/ -- The Cloudburst Group today announced that Dr. Vladimir Knezevic, an innovative leader with a history of success in providing support to clinical and public health research, has joined the firm as Director of its Center for Public Health. In this position, Dr. Knezevic will be responsible for managing and driving the firm's established business in health communications, evaluation research and performance measurement, program planning and technical assistance services; and providing support to client agencies such as the U.S. Centers for Disease Control and Prevention (CDC), the Substance Abuse and Mental Health Services Administration (SAMHSA), the Centers for Medicare and Medicaid Services (CMS) and the United States Agency for International Development (USAID).

Dr. Knezevic has 20 years of management experience complementing his medical training and over a decade of biomedical research experience. Most recently, Dr. Knezevic served as the Director of the Center for Peer Review and Science Management at SRA International, overseeing a group that provides comprehensive science administration support services to government clients. Prior to this position he served as Vice President for Research and Development at 20/20 GeneSystems, a biotechnology company that develops and commercializes innovative diagnostic products based on the patented Layered Gene Scanning platform, for which he contributed to securing private and Federal research funding. Dr. Knezevic also spent 7 years as a research scientist at the National Cancer Institute studying early stages of vertebrate embryonic development and correlating it to cancer growth and progression. He has published 31 papers in peer reviewed journals and has been awarded 5 patents.

Dr. Knezevic holds a Medical Degree in General Medicine from the University of Zagreb Medical School, Zagreb, Croatia.

About The Cloudburst Group

The Cloudburst Consulting Group, Inc. is a small business established in 2005 and headquartered in Landover, Maryland.  Cloudburst is staffed by experienced professionals who work with public and private organizations, both domestically and internationally, to enhance the impact of programs that assist socially and economically disadvantaged persons and communities. 

Contact: Steven T. Sullivan, Ph.D.301-918-4400 sts@cloudburstgroup.com www.cloudburstgroup.com

SOURCE The Cloudburst Group

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 18,203.37 -85.26 -0.47%
S&P 500 2,107.78 -9.61 -0.45%
NASDAQ 4,979.9010 -28.1950 -0.56%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs